National Guideline Clearinghouse | Pembrolizumab for advanced melanoma not previously treated with ipilimumab.

National Guideline Clearinghouse | Pembrolizumab for advanced melanoma not previously treated with ipilimumab.



National Institute for Health and Care Excellence (NICE)

• Pembrolizumab for advanced melanoma not previously treated with ipilimumab.

Guideline Title

Pembrolizumab for advanced melanoma not previously treated with ipilimumab.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Pembrolizumab for advanced melanoma not previously treated with ipilimumab. London (UK): National Institute for Health and Care Excellence (NICE); 2015 Nov 25. 33 p. (Technology appraisal guidance; no. 366).

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.